Testing for Alzheimer’s could soon be done with an at-home blood test

The idea of diagnosing Alzheimer’s with a quick, finger-prick test marks a profound shift in how we could approach ...

JCR Pharmaceuticals' Research Presentations at WORLDSymposium(TM) 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders

JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the presentation of four ...
PharmiWeb

JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders

Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals ...
AHA/ASA Journals

Apolipoprotein D, a Novel Ligand for CD36, Is Essential for Blood–Brain Barrier Integrity

BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...